Delivery Order SPE2DB24D3013-SPE2DB25FFKQS
Award Date
4/2/25
Potential Completion Date
4/3/25
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $33,105.03 and an ultimate completion date of December 18, 2024. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 17, 2024. This appears to be a delivery order contract, with a firm fixed price pricing type. The contract...
This federal contract award is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML medical products to the Defense Logistics Agency (DLA), a defense agency. The $1,574.56 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 26, 2024 with a completion date of November 27, 2024. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,990.50 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through May 6, 2025 and is not designated as a set-aside. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $10,760.60 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 28, 2025. The contract is not designated with a...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of COSENTYX UNOREADY 300 mg PEN 2ml medication. The $3,043.90 firm fixed-price contract has a completion date of May 24, 2024. Amerisourcebergen Drug Corp holds a broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to deliver a range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,149.12 delivery order contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 23, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant...
The federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $4,723.68. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 4, 2024. There is no set-aside designation for this...
This federal contract award is for the supply of COSENTYX SENSOREADY 150 MG PENML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $3,114.84 and is a delivery order, with a firm fixed-price pricing type. The contract does not have a set-aside designation and has an ultimate completion date of August 30, 2024. Amerisourcebergen holds significant Indefinite...
This federal contract award, valued at $10,004.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, and has an ultimate completion date of March 24, 2025. The contract type is Delivery Order with a Firm Fixed Price pricing structure. The contract is not designated as a set-aside. Amerisourcebergen...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product COSENTYX UNOREADY 300 MG PEN 2ML. The contract has a ceiling value of $7,609.75 and a period of performance through April 10, 2024. This award is a child contract associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to...